GC
ELGX

Guggenheim Capital’s Endologix Inc ELGX Stock Holding History

Guggenheim Capital’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,667
Closed -$620K – 3220
2013
Q2 		$620K Buy
+4,667
New +$659K ﹤0.01% 2321

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Guggenheim Capital's ELGX Position: Q3 2013 in Review

Guggenheim Capital sold out of Endologix Inc (ELGX) in Q3 2013, closing a stake of 4,667 shares — an estimated $620K sold.

Guggenheim Capital first reported a position in ELGX in Q2 2013 and held it in 1 quarter. The position peaked at $620K in Q2 2013. 135 funds tracked by Wall St. Rank hold ELGX as of Q3 2013.

  • Guggenheim Capital reported no remaining Endologix Inc position as of Q3 2013 after selling out during the quarter.
  • Guggenheim Capital sold 4,667 Endologix Inc shares in Q3 2013, an estimated $620K.
  • Guggenheim Capital first reported a position in Endologix Inc in Q2 2013 and held it in 1 quarter.
  • Guggenheim Capital's Endologix Inc position peaked at $620K in Q2 2013.
  • 135 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2013.

Based on Guggenheim Capital's 13F filing for Q3 2013, filed 14 Nov 2013.